Fluoxetine for hypochondriacal patients without major depression

Brian A. Fallon, Michael R. Liebowitz, Ester Salmán, Franklin R. Schneier, Carlos Jusino, Eric Hollander, Donald F. Klein

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Hypochondriasis without concomitant depression is often considered to be unresponsive to pharmacotherapy. Given marked similarities between hypochondriasis and obsessive-compulsive disorder, we decided to conduct an open trial of high-dose fluoxetine for patients with DSM-III-R hypochondriasis who did not meet criteria for major depression. Ten of 16 patients were much improved at the end of 12 weeks. A comparison of baseline and week 12 scores by the use of a paired-samples t-test revealed a statistically significant reduction in hypochondriacal concerns, as measured by the Heightened Illness Concern Clinical Global Impression Severity scale, the Whiteley Index of Hypochondriasis, and the Heightened Illness Concern Questionnaire. These results suggest that fluoxetine may be a useful therapy for hypochondriacal patients without marked depressive features—a group previously considered to be treatment refractory.

Original languageEnglish (US)
Pages (from-to)438-441
Number of pages4
JournalJournal of Clinical Psychopharmacology
Volume13
Issue number6
StatePublished - 1993
Externally publishedYes

Fingerprint

Hypochondriasis
Fluoxetine
Depression
Obsessive-Compulsive Disorder
Diagnostic and Statistical Manual of Mental Disorders
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Fallon, B. A., Liebowitz, M. R., Salmán, E., Schneier, F. R., Jusino, C., Hollander, E., & Klein, D. F. (1993). Fluoxetine for hypochondriacal patients without major depression. Journal of Clinical Psychopharmacology, 13(6), 438-441.

Fluoxetine for hypochondriacal patients without major depression. / Fallon, Brian A.; Liebowitz, Michael R.; Salmán, Ester; Schneier, Franklin R.; Jusino, Carlos; Hollander, Eric; Klein, Donald F.

In: Journal of Clinical Psychopharmacology, Vol. 13, No. 6, 1993, p. 438-441.

Research output: Contribution to journalArticle

Fallon, BA, Liebowitz, MR, Salmán, E, Schneier, FR, Jusino, C, Hollander, E & Klein, DF 1993, 'Fluoxetine for hypochondriacal patients without major depression', Journal of Clinical Psychopharmacology, vol. 13, no. 6, pp. 438-441.
Fallon BA, Liebowitz MR, Salmán E, Schneier FR, Jusino C, Hollander E et al. Fluoxetine for hypochondriacal patients without major depression. Journal of Clinical Psychopharmacology. 1993;13(6):438-441.
Fallon, Brian A. ; Liebowitz, Michael R. ; Salmán, Ester ; Schneier, Franklin R. ; Jusino, Carlos ; Hollander, Eric ; Klein, Donald F. / Fluoxetine for hypochondriacal patients without major depression. In: Journal of Clinical Psychopharmacology. 1993 ; Vol. 13, No. 6. pp. 438-441.
@article{d1bff5409f1744fe93715f8324151c0d,
title = "Fluoxetine for hypochondriacal patients without major depression",
abstract = "Hypochondriasis without concomitant depression is often considered to be unresponsive to pharmacotherapy. Given marked similarities between hypochondriasis and obsessive-compulsive disorder, we decided to conduct an open trial of high-dose fluoxetine for patients with DSM-III-R hypochondriasis who did not meet criteria for major depression. Ten of 16 patients were much improved at the end of 12 weeks. A comparison of baseline and week 12 scores by the use of a paired-samples t-test revealed a statistically significant reduction in hypochondriacal concerns, as measured by the Heightened Illness Concern Clinical Global Impression Severity scale, the Whiteley Index of Hypochondriasis, and the Heightened Illness Concern Questionnaire. These results suggest that fluoxetine may be a useful therapy for hypochondriacal patients without marked depressive features—a group previously considered to be treatment refractory.",
author = "Fallon, {Brian A.} and Liebowitz, {Michael R.} and Ester Salm{\'a}n and Schneier, {Franklin R.} and Carlos Jusino and Eric Hollander and Klein, {Donald F.}",
year = "1993",
language = "English (US)",
volume = "13",
pages = "438--441",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Fluoxetine for hypochondriacal patients without major depression

AU - Fallon, Brian A.

AU - Liebowitz, Michael R.

AU - Salmán, Ester

AU - Schneier, Franklin R.

AU - Jusino, Carlos

AU - Hollander, Eric

AU - Klein, Donald F.

PY - 1993

Y1 - 1993

N2 - Hypochondriasis without concomitant depression is often considered to be unresponsive to pharmacotherapy. Given marked similarities between hypochondriasis and obsessive-compulsive disorder, we decided to conduct an open trial of high-dose fluoxetine for patients with DSM-III-R hypochondriasis who did not meet criteria for major depression. Ten of 16 patients were much improved at the end of 12 weeks. A comparison of baseline and week 12 scores by the use of a paired-samples t-test revealed a statistically significant reduction in hypochondriacal concerns, as measured by the Heightened Illness Concern Clinical Global Impression Severity scale, the Whiteley Index of Hypochondriasis, and the Heightened Illness Concern Questionnaire. These results suggest that fluoxetine may be a useful therapy for hypochondriacal patients without marked depressive features—a group previously considered to be treatment refractory.

AB - Hypochondriasis without concomitant depression is often considered to be unresponsive to pharmacotherapy. Given marked similarities between hypochondriasis and obsessive-compulsive disorder, we decided to conduct an open trial of high-dose fluoxetine for patients with DSM-III-R hypochondriasis who did not meet criteria for major depression. Ten of 16 patients were much improved at the end of 12 weeks. A comparison of baseline and week 12 scores by the use of a paired-samples t-test revealed a statistically significant reduction in hypochondriacal concerns, as measured by the Heightened Illness Concern Clinical Global Impression Severity scale, the Whiteley Index of Hypochondriasis, and the Heightened Illness Concern Questionnaire. These results suggest that fluoxetine may be a useful therapy for hypochondriacal patients without marked depressive features—a group previously considered to be treatment refractory.

UR - http://www.scopus.com/inward/record.url?scp=0027716672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027716672&partnerID=8YFLogxK

M3 - Article

C2 - 8120157

AN - SCOPUS:0027716672

VL - 13

SP - 438

EP - 441

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 6

ER -